This clinical trial evaluates the feasibility of coaching-based navigation for black breast cancer survivors including recruitment, dropout, and survey completion rates. A coaching-based navigation may perform a needs assessment and coach the participant to access relevant supportive content including physical rehabilitation, emotional and psychosocial support, and nutrition and exercise programming. This trial aims to see whether this navigation program may improve the quality of life of black breast cancer survivors.
PRIMARY OBJECTIVE: I. To evaluate the feasibility of coaching-based navigation for black breast cancer survivors including recruitment, dropout, and survey completion rates. SECONDARY OBJECTIVES: I. To evaluate the preliminary impact of health coaching on completion of scheduled survivorship related referrals and participation in support services. II. To determine the preliminary impact on quality of life and self-efficacy pre and post coaching. OUTLINE: Patients are assigned a Black patient navigator for racial concordance and receive coaching from patient navigator over 30 minutes every other week for 3 months and then monthly for 3 months.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
21
Assigned a patient navigator and receive coaching
Ancillary studies
Ancillary studies
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Recruitment rate
Will be calculated as the number of new eligible women per month.
Time frame: Up to 6 months
Consent rate
Will be calculated as the number of consented women (set to 40 for this study) divided by the total number of women approached.
Time frame: Up to 6 months
Dropout rate
Will be calculated as the percentage of women who are enrolled in the study but withdraw before the conclusion of the study.
Time frame: Up to 6 months
Patient-Reported Outcomes Measurement Information System score
Differences in scoring at the start of the study period and at the end of the trial will also be summarized by mean, standard deviation, and range.
Time frame: Up to 6 months
European Organization for Research and Treatment of Cancer Quality of Life-30 score
Differences in scoring at the start of the study period and at the end of the trial will also be summarized by mean, standard deviation, and range.
Time frame: Up to 6 months
Breast Cancer Self Efficacy Scale score
A self reported, unidimensional, 11 item scale designed to show the differences in scoring at the start of the study period and at the end of the trial will also be summarized by mean, standard deviation, and range.
Time frame: Up to 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.